Cologuard is a non-invasive stool test that is 92% accurate in detecting active colon cancer. This is available through our office and may be a safe, accurate option to colonoscopy.

Cologuard was pulled from the market several years ago by the FDA. It is now back and can be ordered through the mail if you are a patient of Metta Health Care.

The sales representative says this test is covered by medicare and most insurances every 3 years (if the person hasn’t had a colonoscopy). The out-of-pocket price is about $600 if you don’t have insurance.

This test may be a good option for people who don’t have a family or personal history of colon cancer, and want a non-invasive option for colon cancer screening.

This may come at an opportune moment when an article has exposed inadequate sterilization of colonoscopes in large medical institutions.

Read more.